Immune4Life Guide · P027
Editorial and Medical Review Policy
Immune4Life publishes YMYL content about supplements, immune biology, health claims, research, buying decisions, and a direct-selling business opportunity.
The editorial system must prioritize accuracy, transparency, current information, and visible limitations.
Authorship
Every published page should identify:
- author;
- relevant qualifications or experience;
- reviewer when applicable;
- original publication date;
- last substantive review date.
Scientific and medical review
Pages involving physiology, safety, dosage, interactions, pregnancy, children, disease terminology, or clinical research should receive appropriate qualified review.
A reviewer confirms factual and interpretive quality. Review does not convert general education into individualized medical advice.
Source hierarchy
Priority order:
- current official product label;
- FDA, FTC, NIH, CDC, NIAID, NCCIH, and other primary public bodies;
- peer-reviewed primary studies;
- systematic reviews and evidence reports;
- official certifier databases;
- official company documents;
- secondary expert sources;
- consumer reviews for experience only.
Company claims
Official 4Life positioning must be attributed clearly and separated from independent interpretation.
Study interpretation
Every material research claim should identify:
- study type;
- exact material or product;
- route;
- dose;
- population;
- outcome;
- funding;
- limitations;
- product relevance.
Current-label verification
Product pages must be checked against the current U.S. label. Old catalogs, marketplace listings, and international pages are not controlling.
Affiliate and commercial review
Affiliate revenue does not permit suppression of safety information or inflation of evidence.
Commercial pages must include visible Affiliate disclosure.
AI assistance
AI may assist with structure, drafting, comparison, metadata, or editorial QA. Human review remains required for facts, citations, current product data, and compliance.
Corrections
Material errors should be corrected promptly.
A correction record should include:
- what changed;
- why;
- date;
- whether the conclusion changed.
Article updates
Review frequency should reflect change risk:
- product and price pages: frequent review;
- business-program pages: frequent review;
- safety pages: scheduled and event-driven review;
- stable immune-biology pages: periodic review.
Reader feedback
Readers can report errors through the Contact page. Evidence should be reviewed without retaliation or commercial bias.
Sources and current-reference pages
- https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-substantiation-dietary-supplement-claims-made-under-section-403r-6-federal-food
- https://www.ncbi.nlm.nih.gov/books/NBK305518/
Important disclosure
Immune4Life is an independent 4Life Affiliate education website and is not the 4Life corporate website. Some links may open an official personalized 4Life MyShop and may result in Affiliate credit or commission.
Product formulas, labels, prices, availability, compensation rules, customer programs, qualifications, and company policies can change. Current official U.S. 4Life documents and checkout control.
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. This page is educational and is not individualized medical, legal, tax, or financial advice. Earnings are not guaranteed.
Editorial status: review pending. Last verified: 2026-07-21 source baseline; editorial approval pending.
